Remove 2017 Remove Diabetes Remove Generic Medicine
article thumbnail

Pathbreakers: The journey of first generics

Pharmaceutical Technology

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.

article thumbnail

Cracking the code – Generic vs. Brand Medicines

Express Pharma

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Annually, about 2,827 brands with a total value of Rs. 3,810 crores were introduced.